Study Assessing Tolerability and Safety and Exploring the Immunogenicity and Therapeutic Activity of AFFITOPE® PD01A in PD-GBA Patients
Condition(s):Parkinson’s DiseaseLast Updated:August 5, 2016Withdrawn
Hide Studies Not Open or Pending
Condition(s):Parkinson’s DiseaseLast Updated:August 5, 2016Withdrawn
Condition(s):Parkinson’s DiseaseLast Updated:June 5, 2017Completed
Condition(s):HypercholesterolemiaLast Updated:October 20, 2017Completed
Condition(s):Multiple System Atrophy; Neurodegenerative DiseasesLast Updated:June 5, 2017Completed
Condition(s):Parkinson Disease; Neurodegenerative DiseasesLast Updated:October 31, 2016Completed
Condition(s):Parkinson’s DiseaseLast Updated:August 17, 2015Completed
Condition(s):Alzheimer´s DiseaseLast Updated:June 24, 2015Terminated
Condition(s):Parkinson’s DiseaseLast Updated:August 17, 2015Completed
Condition(s):Parkinson’s DiseaseLast Updated:August 17, 2015Completed
Condition(s):Alzheimer’s DiseaseLast Updated:November 6, 2013Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.